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  P-glycoprotein (P-gp) is encoded by the ABCB1 gene and 
acts  as  an  efflux  pump  for  xenobiotics.  In  the  Border 
Collie,  a  nonsense  mutation  caused  by  a  4-base  pair 
deletion in the ABCB1 gene is associated with a premature 
stop to P-gp synthesis. In this study, we examined the full- 
length coding sequence of the ABCB1 gene in an ivermectin- 
sensitive  Border  Collie  that  lacked  the  aforementioned 
deletion  mutation.  The  sequence  was  compared  to  the 
corresponding sequences of a wild-type Beagle and seven 
ivermectin-tolerant family members of the Border Collie. 
When compared to the wild-type Beagle sequence, that of 
the ivermectin-sensitive Border Collie was found to have 
one  insertion  mutation  and  eight  single  nucleotide 
polymorphisms (SNPs) in the coding sequence of the ABCB1 
gene. While the eight SNPs were also found in the family 
members’  sequences,  the  insertion  mutation  was  found 
only in the ivermectin-sensitive dog. These results suggest 
the possibility that the SNPs are species-specific features 
of  the  ABCB1  gene  in  Border  Collies,  and  that  the 
insertion mutation may be related to ivermectin intolerance.
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polymorphism
Introduction 
P-glycoprotein (P-gp), encoded by the ABCB1 gene 
(formerly known as MDR1), is a membrane transport 
protein in the ATP-binding cassette superfamily [16]. P-gp 
is normally expressed in various mammalian tissues 
including the apical border of intestinal epithelial cells, 
brain capillary endothelial cells, biliary canalicular cells, 
renal proximal tubular epithelial cells, placenta, and testes 
[4,9,14,17,21]. P-gp functions as an efflux pump on the cell 
membrane, and thus protects the cell from potentially toxic 
xenobiotics [16]. Several polymorphisms of the ABCB1 
gene are known to cause deformations and dysfunctions of 
P-gp in humans [3,6,12,18], while in ivermectin-sensitive 
Collies, a frame shift mutation has been found which 
causes a premature stop to P-gp synthesis [7,19].
We examined a Border Collie with depression, 
hypersalivation, and several other adverse reactions which 
developed following ivermectin intake for heartworm 
treatment. None of its family members showed any 
adverse reactions to ivermectin administration. DNA 
analysis, however, did not reveal the previously described 
frame shift mutation in the ivermectin-sensitive Border 
Collie. For this reason, we examined the full-coding 
sequence of the ABCB1 gene in the ivermectin-sensitive 
Border Collie, and compared the sequence to those of its 
family members and to wild-type Beagles in order to 
investigate the possibility of different mutations.
Materials and Methods
Peripheral blood samples were collected from the 
cephalic veins of the ivermectin-sensitive Border Collie 
and its seven family members. Total RNA was extracted 
from the peripheral blood using TRIzol reagent (Invitrogen, 
USA). The total RNA was reverse transcribed into 
first-strand cDNA using a random hexamer primer and the 
Superscript first-strand synthesis system of the RT-PCR kit 
(Invitrogen, USA). 
To verify the family relationship between the Border 
Collies, a 261-bp mitochondrial D-loop region was 
amplified using the primers L15910 and H16498 as 
previously described [5]. All PCR products were sequenced 
using an ABI Prism BigDye terminator cycle sequencing 
ready reaction kit v.5.1 (PE Applied Biosystems, USA) 
and the sequences were compared.
We designed primers to amplify the coding sequence of 
the ABCB1 gene; these were based on the wild-type Beagle 
ABCB1 gene sequence (GenBank accession number 
NM_001003215). Each primer was designed to contain 342    Jae-Ik Han et al.
Table 1. Oligo-sequences of the primers used in this study
Target Product Annealing 
Name Sequence (5´ to 3´)
sequence size (bp) temperature (
oC)
MDR F1 GTCGG AGTAT CTTCT TCCCA AA
5-566 557 57
MDR R1 ACGTC AAACC AGCCA ATCTC
MDR F2 TCATG ATGCT GGTTT TTGGA
266-829 564 55
MDR R2 CTGCT CCAGC TTTTG CATAG
MDR F3 TGGTT GGAAG CTAAC CCTTG
702-1341 640 57
MDR R3 CACTG TCTGC CCACT CTGAA
MDR F4 GTTCA CTTCA GTTAC CCTTC TCG
1261-1884 624 55
MDR R4 TCCAT CATCA AAACC AGCAA
MDR F5 AAGAT TCTTC TGCTG GATGA GG
1720-2327 608 57
MDR R5 CTATT CTGTC GTTTT GTTTC AGGA
MDR F6 CTGCA ACCAG CATTT TCAAT AATA
2242-2852 611 55
MDR R6 GGTAC TTGCA AACTC TGTGC ATAC
MDR F7 CTGGA CAAGC ACTGA AAGAT AAGA
2711-3376 666 55
MDR R7 TTATC TCTTT GCCAT CAATT AGCA
MDR F8 AGCAC AGTTG TTCAG CTCCT AGA
3301-4043 743 57
MDR R8 GCAGC AAGAA ATGTT AAACA GGTA
Fig. 1. Pedigree analysis showing the relationships of the 
ivermectin-sensitive Border Collie and its seven family 
members. The black square indicates the ivermectin-sensitive 
Border Collie.
overlapping sequences of 100∼200 bp at both ends of the 
PCR products. The conditions of the designed primers 
were verified using DNAMAN software v.4.16 (Lynnon, 
Canada). Primer information is listed in Table 1. PCR 
amplification was performed as follows: one cycle at 94
oC 
for 5 min; 35 cycles at 94
oC for 30 sec at the primer 
annealing temperature (55∼57
oC) for 30 sec, followed by 
at 72
oC for 1 min. The sizes of the resultant PCR products 
were analyzed using 2% agarose gel electrophoresis.
All PCR products were sequenced using the ABI Prism 
BigDye terminator cycle sequencing ready reaction kit 
v.5.1 (PE Applied Biosystems, USA). Finally, all identified 
sequences were merged (except the overlapping sequences) 
and compared using CLC sequence viewer v.4.6.2 (CLC 
Bio, Denmark).
Results
Fig. 1 shows the family pedigree of the Border Collies. 
All Border Collies except for the father showed the same 
nucleotide sequence in the 261-bp mitochondrial D-loop 
region. There was a 99% similarity between the father and 
the rest of the family.
When compared to the coding sequence of the ABCB1 
gene in wild-type Beagle dogs, one insertion mutation and 
eight single nucleotide polymorphisms (SNPs) were found 
at the nucleotide level in the ivermectin-sensitive Border 
Collie (Fig. 2). Three nucleotides (‘AAT’) were inserted 
between the 72nd and 73rd nucleotide of the ABCB1 
coding sequence. The eight SNPs were characterized as 
G574A, C635G, A985T, G996A, G1595A, T2082A, 
T2086C, and A3817G. At the protein level, the insertion 
mutation led to the addition of an asparagine between the 
24th and 25th amino acids. Six of the SNPs lead to amino 
acid exchanges (Val192Ile, Pro212Arg, Thr329Ser, 
Arg532Gln, Ser696Pro, and Ile273Val), while G996A and 
T2082A resulted in silent mutations. All SNPs were also 
examined in all of the Border Collie family members; 
however, the insertion mutation was observed only in the 
ivermectin-sensitive Border Collie.
Discussion
P-gp was first discovered in 1976 in a Chinese hamster 
ovary (CHO) cell line that was selected in culture for 
colchicine resistance [10]. Resistant CHO cells expressed 
large quantities of a 170-kD protein, subsequently named Novel insertion mutation of ABCB1 gene in an ivermectin-sensitive Border Collie    343
Fig. 2. Diagram showing the location of mutations in the coding sequence of the ABCB1 gene and P-glycoprotein (P-gp). The arrow 
indicates the position of the insertion mutation and arrowheads show the positions of single nucleotide polymorphisms. Underbars 
indicate the positions of insertion or substitution of nucleotides in the ABCB1 gene or amino acids in the P-gp molecule.
P-gp. Since then, several drugs have been identified as 
substrates of P-gp [6]. In dogs, ivermectin sensitivity 
caused by a nonsense mutation of the ABCB1 gene is a 
well-recognized phenomenon [19]; however, the full 
sequence of the ABCB1 gene is only available for the 
wild-type Beagle. Therefore, we first established the 
ABCB1 coding sequence in wild-type Border Collies and 
compared that to the wild-type Beagle sequence. We found 
eight SNPs in all wild-type Border Collies. Taking into 
account interethnic variation in the human ABCB1 
sequence [1,20], our finding suggests that the canine 
ABCB1 sequence may demonstrate interbreed variation. 
For this reason, we recommend that the ABCB1 gene 
sequence be confirmed in each breed of dog prior to 
molecular investigation for mutations.
Using the wild-type Border Collie sequence examined in 
this study as a baseline for comparison, we investigated 
alterations in the sequence of the ABCB1 gene in an 
ivermectin-sensitive Border Collie that lacked the expected 
frameshift mutation. While eight SNPs were found in all of 
the study Border Collies, an insertion mutation was found 
only in the ivermectin-sensitive animal. The conformational 
change of P-gp is important for the protein’s role as an 
efflux pump through interaction between the drug-binding 
and nucleotide-binding domains [15]. In the human 
ABCB1 gene, several SNPs have been identified that can 
lead to decreased P-gp function [6]. Furthermore, a silent 
mutation in the ABCB1 gene has been found to be 
associated with the level of P-gp expression in humans [8]. 
Deformation of protein structure caused by the addition or 
substitution of a single amino acid also induces several 
diseases in human and animals [2,13]. Malfunction of P-gp 
has often been noted in Collies and can occur either by 
decreased expression of a functional gene or by a gene 
mutation that impairs protein concentration or activity 
[19]. The eight SNPs identified in this study do not appear 
to be directly related to the adverse reactions displayed by 
the ivermectin-sensitive Border Collie, suggesting the 
possibility that these polymorphisms of the ABCB1 gene 
are related to the interbreed variation in P-gp function seen 
in dogs.
Since mitochondrial DNA is inherited exclusively from 
the mother, it can be used as a tool for tracking maternal 
lineage [23]. A D-loop-containing region that has a highly 
variable sequence is commonly used for phylogenetic 
analysis [11,22,24]. To verify the family relationship of the 
Border Collies, we sequenced the D-loop region and found 
that all family members expressed the same sequence 
except for the father dog. The similarity between the father 
dog and the rest of the family was 99%. According to the 
GenBank database, the similarity of the sequence of canine 
D-loop regions is 98∼99%. This suggests that the SNPs of 
the ABCB1 coding sequence identified in this study are a 
universal feature of Border Collies.
In conclusion, we found a new insertion mutation of the 
ABCB1 gene in an ivermectin-sensitive Border Collie. 
This mutation was not seen in its healthy family members 
or in the normal Beagle. Additionally, we described eight 
SNPs in the wild-type Border Collies. This finding 
suggests the possibility that dogs display interbreed 
variation in the ABCB1 sequence. The sequence of the 
ABCB1 gene should be established in each breed of dog 
prior to molecular investigation of the ABCB1 gene and 
P-gp.
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